Altered Ratio of IFN-γ/IL-10 in Patients with Drug Resistant Mycobacterium tuberculosis and HIV- Tuberculosis Immune Reconstitution Inflammatory Syndrome

PLoS ONE

Volumn 7, Issue 10, 2012, Pages

  Skolimowska, Keira H ^a,c   Rangaka, Molebogeng X ^a   Meintjes, Graeme ^a,c,d   Pepper, Dominique J ^d   Seldon, Ronnett ^a   Matthews, Kerryn ^a   Wilkinson, Robert J ^a,b,c,d   Wilkinson, Katalin A ^a,b  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b NATIONAL INSTITUTE FOR MEDICAL RESEARCH   (United Kingdom)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d GF Jooste Hospital   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CRYSTALLIN; EARLY SECRETORY ANTIGENIC TARGET 6; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12P40; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; RIFAMPICIN; TUBERCULIN; TUMOR NECROSIS FACTOR;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL LOAD; BACTERIAL STRAIN; BACTERIUM ISOLATION; CELL STIMULATION; CLINICAL ARTICLE; CYTOKINE RELEASE; DRUG TREATMENT FAILURE; ENZYME LINKED IMMUNOSPOT ASSAY; FEMALE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; IMMUNE RESPONSE; MALE; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; SUPERNATANT; TUBERCULOSIS;

ADULT; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INTERFERON-GAMMA; INTERLEUKIN-10; MALE; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 84867338433     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0046481     Document Type: Article

References (28)

1. Badri M, Wilson D, Wood R, (2002) Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359: 2059-2064.
2. Lawn SD, Badri M, Wood R, (2005) Tuberculosis among HIV-infected patients receiving HAART: long term incidence and risk factors in a South African cohort. AIDS 19: 2109-2116.
3. Middelkoop K, Bekker LG, Myer L, Johnson LF, Kloos M, et al. (2011) Antiretroviral therapy and TB notification rates in a high HIV prevalence South African community. Journal of acquired immune deficiency syndromes 56: 263-269.
4. Oni T, Burke R, Tsekela R, Bangani N, Seldon R, et al. (2011) High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 66: 669-673.
5. Meintjes G, Wilkinson RJ, (2010) Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapy. Clin Infect Dis 51: 830-832.
6. Haddow LJ, Easterbrook PJ, Mosam A, Khanyile NG, Parboosing R, et al. (2009) Defining immune reconstitution inflammatory syndrome: evaluation of expert opinion versus 2 case definitions in a South African cohort. Clin Infect Dis 49: 1424-1432.
7. Haddow LJ, Moosa MY, Easterbrook PJ, (2010) Validation of a published case definition for tuberculosis-associated immune reconstitution inflammatory syndrome. Aids 24: 103-108.
8. Meintjes G, Lawn SD, Scano F, Maartens G, French MA, et al. (2008) Tuberculosis-associated immune reconstitution inflammatory syndrome: case definitions for use in resource-limited settings. Lancet Infect Dis 8: 516-523.
9. Meintjes G, Rangaka MX, Maartens G, Rebe K, Morroni C, et al. (2009) Novel relationship between tuberculosis immune reconstitution inflammatory syndrome and antitubercular drug resistance. Clin Infect Dis 48: 667-676.
10. Lawn SD, Wilkinson R, (2006) Extensively drug resistant tuberculosis. BMJ 333: 559-560.
11. Andrews JR, Shah NS, Weissman D, Moll AP, Friedland G, et al. (2010) Predictors of multidrug- and extensively drug-resistant tuberculosis in a high HIV prevalence community. PLoS ONE 5: e15735.
12. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. Lancet 377: 1495-1505.
13. Gandhi NR, Moll A, Sturm AW, Pawinski R, Govender T, et al. (2006) Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368: 1575-1580.
14. Cox HS, McDermid C, Azevedo V, Muller O, Coetzee D, et al. (2010) Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS ONE 5: e13901.
15. Geffner L, Yokobori N, Basile J, Schierloh P, Balboa L, et al. (2009) Patients with multidrug-resistant tuberculosis display impaired Th1 responses and enhanced regulatory T-cell levels in response to an outbreak of multidrug-resistant Mycobacterium tuberculosis M and Ra strains. Infect Immun 77: 5025-5034.
16. Tadokera R, Meintjes G, Skolimowska KH, Wilkinson KA, Matthews K, et al. (2011) Hypercytokinaemia accompanies HIV-tuberculosis immune reconstitution inflammatory syndrome. Eur Respir J 37: 1248-1259.
17. Meintjes G, Wilkinson KA, Rangaka MX, Skolimowska K, van Veen K, et al. (2008) Type 1 helper T cells and FoxP3-positive T cells in HIV-tuberculosis-associated immune reconstitution inflammatory syndrome. Am J Respir Crit Care Med 178: 1083-1089.
18. Wu YE, Peng WG, Cai YM, Zheng GZ, Zheng GL, et al. (2010) Decrease in CD4+CD25+FoxP3+ Treg cells after pulmonary resection in the treatment of cavity multidrug-resistant tuberculosis. Int J Infect Dis 14: e815-822.
19. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, et al. (2001) Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 167: 5217-5225.
20. Jamil B, Shahid F, Hasan Z, Nasir N, Razzaki T, et al. (2007) Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis. Tuberculosis (Edinb) 87: 279-287.
21. Eum SY, Jeon BY, Min JH, Kim SC, Cho S, et al. (2008) Tumor necrosis factor-alpha and interleukin-10 in whole blood is associated with disease progression in pulmonary multidrug-resistant tuberculosis patients. Respiration 76: 331-337.
22. Saraiva M, O'Garra A, (2010) The regulation of IL-10 production by immune cells. Nat Rev Immunol 10: 170-181.
23. Redford PS, Murray PJ, O'Garra A, (2011) The role of IL-10 in immune regulation during M. tuberculosis infection. Mucosal Immunol 4: 261-270.
24. Remoli ME, Giacomini E, Petruccioli E, Gafa V, Severa M, et al. (2011) Bystander inhibition of dendritic cell differentiation by Mycobacterium tuberculosis-induced IL-10. Immunology and cell biology 89: 437-446.
25. Newton SM, Smith RJ, Wilkinson KA, Nicol MP, Garton NJ, et al. (2006) A deletion defining a common Asian lineage of Mycobacterium tuberculosis associates with immune subversion. Proc Natl Acad Sci U S A.
26. Guyot-Revol V, Innes JA, Hackforth S, Hinks T, Lalvani A, (2006) Regulatory T cells are expanded in blood and disease sites in patients with tuberculosis. Am J Respir Crit Care Med 173: 803-810.
27. de Araujo-Filho JA, Vasconcelos AC Jr, Martins de Sousa E, Kipnis A, Ribeiro E, et al. (2008) Cellular responses to MPT-51, GlcB and ESAT-6 among MDR-TB and active tuberculosis patients in Brazil. Tuberculosis (Edinb) 88: 474-481.
28. Flynn JL, Chan J, (2003) Immune evasion by Mycobacterium tuberculosis: living with the enemy. Curr Opin Immunol 15: 450-455.